[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"meningococcal-infection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:meningococcal-infection":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100427215","observational-passive-surveillance-program-to-collect-information-on-women-and-their-offspring-exposed-to-menquadfi-during-pregnancy-in-united-states-us-100427215",false,"NCT04843111","Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)","The MenQuadfi® Pregnancy Registry: A Surveillance Registry to Assess the Safety of MenQuadfi® Among Exposed Pregnant Women and Their Offspring","Inclusion Criteria:\n\nThe eligible population will include pregnant women and their offspring residing in the US and its territories who are exposed to MenQuadfi® during their pregnancy or within 30 days prior to their LMP, for whom the exposure is reported to the pregnancy registry.\n\nReports of MenQuadfi® pregnancy exposure must contain the following information:\n\n* Sufficient evidence to confirm that vaccination occurred during the pregnancy or in the 30 days preceding the LMP;\n* Vaccine name (brand or generic) is provided (i.e., MenQuadfi®, Meningococcal vaccine, MenACWY conjugate vaccine), or not specified (eg, meningococcal vaccine from an unknown manufacturer).\n\nExclusion Criteria:\n\nOnly post-marketing spontaneous case reports will be included; reports from clinical trials will not be part of the registry.\n\nThe above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.",true,"ALL",{"count":19,"type":20},50,"ESTIMATED","22 Months","OBSERVATIONAL","Primary Objective:\n\nTo assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women vaccinated with MenQuadfi® during pregnancy or in the 30 days preceding their Last Menstrual Period (LMP).",[25],"Meningococcal Infection","RECRUITING","2025-11-27",{"date":29,"type":30},"2025-12-01","ACTUAL",{"date":32,"type":30},"2021-03-05",{"date":34,"type":20},"2028-05-18",{"name":36,"class":37},"Sanofi Pasteur, a Sanofi Company","INDUSTRY"]